Sarah Benafif and Mel Erwin about the new lung cancer vaccine trial that opened in the UK – Oncogene Cancer Research

Oncogene Cancer Research shared on X:

“Listen to this BBC Radio 5 Live segment to hear UCLH‘s Dr. Sarah Benafif and lung cancer advocate Mel Erwin speak about the new lung cancer vaccine trial that opened in the UK yesterday.

The mRNA jab aims to help immune sys find and fight cancer cells.”

Source: Oncogene Cancer Research/X

Other posts featuring Oncogene Cancer Research on OncoDaily.

Sarah Benafif is a Medical Oncology Consultant at University College London Hospitals NHS Foundation Trust, specializing in lung cancer. She leads clinical trials focused on pioneering cancer treatments, with a particular emphasis on advanced therapies like mRNA vaccines.

Mel Erwin, a lung cancer survivor, is a key advocate for the disease. Mel works with the Lung Cancer Research Foundation and the American Lung Association, focusing on awareness campaigns, legislative advocacy, and fundraising. Erwin’s efforts are aimed at advancing research, improving early detection, and enhancing patient support.